Target intelligence / Profile preview

AZGP1 pseudogene 2 (AZGP1P2)

Target
AZGP1P2
Molecular classification
Other (Pseudogene)
01

Overview

AZGP1 pseudogene 2 (AZGP1P2), also listed as Putative zinc-alpha-2-glycoprotein-like 2 and similar names, is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but typically lack protein-coding potential and do not produce functional proteins. AZGP1P2 is related by sequence to the functional gene AZGP1 (encoding zinc-alpha-2-glycoprotein), but it does not encode a functional protein and has no demonstrated, direct biological or therapeutic relevance. There is no evidence it serves as a drug target, biomarker, or mediator of biological functions or disease. In the context of molecular targeting, only the functional AZGP1 gene/protein (not the pseudogene AZGP1P2) is referenced in the literature as involved in lipid metabolism, immune regulation, or cancer biology[1][2][3][4][5][6]. The pseudogene entry does not correspond to a clinically or pharmacologically actionable target; its inclusion as a protein or receptor would be incorrect. Note: If you are seeking information on a therapeutic target, AZGP1 (not AZGP1P2) may be of interest. AZGP1 itself is a functional protein with roles in lipid metabolism and cancer but AZGP1P2 is a non-coding, non-functional pseudogene.

Other names
Putative zinc-alpha-2-glycoprotein-like 2Alpha-2-glycoprotein 1, zinc pseudogene 2Alpha-2-glycoprotein 1, zinc-binding pseudogene 2AZGP1P2

Beyond the preview

Go deeper on AZGP1 pseudogene 2 (AZGP1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AZGP1 pseudogene 2 (AZGP1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call